HK1077521A1 - 找出伴放線杆菌抗原，應用於診斷、治療及監控牙周病 - Google Patents

找出伴放線杆菌抗原，應用於診斷、治療及監控牙周病

Info

Publication number
HK1077521A1
HK1077521A1 HK06100041.3A HK06100041A HK1077521A1 HK 1077521 A1 HK1077521 A1 HK 1077521A1 HK 06100041 A HK06100041 A HK 06100041A HK 1077521 A1 HK1077521 A1 HK 1077521A1
Authority
HK
Hong Kong
Prior art keywords
antigens
diagnosis
identification
monitoring
treatment
Prior art date
Application number
HK06100041.3A
Other languages
English (en)
Inventor
Martin Handfield
Jeffrey Daniel Hillman
Ann Progulske-Fox
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of HK1077521A1 publication Critical patent/HK1077521A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
HK06100041.3A 2001-11-28 2006-01-04 找出伴放線杆菌抗原，應用於診斷、治療及監控牙周病 HK1077521A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/995,493 US7052860B2 (en) 2001-11-28 2001-11-28 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
PCT/US2002/037235 WO2003068146A2 (en) 2001-11-28 2002-11-20 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases

Publications (1)

Publication Number Publication Date
HK1077521A1 true HK1077521A1 (zh) 2006-02-17

Family

ID=27735093

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06100041.3A HK1077521A1 (zh) 2001-11-28 2006-01-04 找出伴放線杆菌抗原，應用於診斷、治療及監控牙周病

Country Status (7)

Country Link
US (5) US7052860B2 (zh)
EP (3) EP2356994A3 (zh)
JP (1) JP2005531288A (zh)
AU (1) AU2002365939A1 (zh)
CA (1) CA2452854A1 (zh)
HK (1) HK1077521A1 (zh)
WO (1) WO2003068146A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004045499A2 (en) * 2002-11-20 2004-06-03 University Of Florida Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
US7052860B2 (en) 2001-11-28 2006-05-30 University Of Florida Research Foundation Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
JP2006519586A (ja) * 2002-11-20 2006-08-31 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド 歯周疾患の診断、治療、およびモニタリングのためのアクチノバチルス・アクチノミセテムコミタンス抗原の同定

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4474893A (en) 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
GB8924473D0 (en) 1989-10-31 1989-12-20 Connaught Lab Outer membrane protein p1 and peptides of haemophilus influenzae b
CA2032959A1 (en) * 1990-01-22 1991-07-23 Brian A. Snyder Article, test kit and sandwich assay for the detection of bacteroides intermedius, bacteroides gingivalis or actinobacillus actinomycetemcomotams
CA2028681A1 (en) * 1990-01-22 1991-07-23 Brian A. Snyder Differentiation of microorganisms associated with periodontal diseases, article and kit useful therein
CA2032114A1 (en) * 1990-01-22 1991-07-23 Brian A. Snyder Antibody composition for actinobacillus actinomycetemcomitans and its use in diagnostics
US5334503A (en) * 1991-10-08 1994-08-02 Eastman Kodak Company Test kit and method for the detection of microorganisms associated with periodontal diseases using surfactant mixture as extraction composition
US6583275B1 (en) * 1997-07-02 2003-06-24 Genome Therapeutics Corporation Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics
US6562958B1 (en) * 1998-06-09 2003-05-13 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
TWI224107B (en) * 1998-10-22 2004-11-21 Pfizer Prod Inc Novel proteins from actinobacillus pleuropneumoniae
US6713071B1 (en) 1998-10-22 2004-03-30 Pfizer Inc. Proteins from actinobacillus pleuropneumoniae
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
DE60040804D1 (de) 1999-08-06 2008-12-24 Oragenics Inc Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden
WO2002077183A2 (en) 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
US7052860B2 (en) 2001-11-28 2006-05-30 University Of Florida Research Foundation Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
WO2004045499A2 (en) * 2002-11-20 2004-06-03 University Of Florida Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases

Also Published As

Publication number Publication date
WO2003068146A3 (en) 2005-05-06
AU2002365939A1 (en) 2003-09-04
JP2005531288A (ja) 2005-10-20
US20110065132A1 (en) 2011-03-17
EP2363138A1 (en) 2011-09-07
EP1551434A2 (en) 2005-07-13
EP2356994A3 (en) 2011-12-07
WO2003068146A2 (en) 2003-08-21
AU2002365939A8 (en) 2003-09-04
US20060035293A1 (en) 2006-02-16
US7498143B2 (en) 2009-03-03
US7052860B2 (en) 2006-05-30
CA2452854A1 (en) 2003-08-21
US8420340B2 (en) 2013-04-16
US20090142782A1 (en) 2009-06-04
EP1551434A4 (en) 2006-11-08
EP2356994A2 (en) 2011-08-17
US20060160159A1 (en) 2006-07-20
US7851171B2 (en) 2010-12-14
US7981631B2 (en) 2011-07-19
US20110294146A1 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
ATE216875T1 (de) Nichtinvasive impfung durch die haut
AU2001229778A1 (en) Health care payment and compliance system
EP1390711A4 (en) SYSTEM FOR MONITORING THE OBSERVANCE OF A TREATMENT
DK1335678T3 (da) Oralt behandlingssystem
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
NO20005990L (no) Platinumkompleks, dets fremstilling og terapeutiske anvendelse
GB0004531D0 (en) The treatment of respiratory diseases
MXPA03006629A (es) Composicion para el cuidado de la piel.
GB0108671D0 (en) Skin treatment
HK1077521A1 (zh) 找出伴放線杆菌抗原，應用於診斷、治療及監控牙周病
NO20005919L (no) Platinakompleks, dets fremstilling og terapeutisk anvendelse
EP1509240A4 (en) IDENTIFICATION OF ANTIGENS OF ACTINOBACILLUS ACTINOMYCETEMCOMITANS USED IN THE DIAGNOSIS, TREATMENT AND MONITORING OF PERIODONTAL DISEASES
GB2371744B (en) Hair Treatment Device
PL373490A1 (en) Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases
AU2001253886A1 (en) Methylxanthines in the diagnosis and treatment of autistic disorder
EP1322778A4 (en) APPLICATION OF CYR61 IN THE TREATMENT AND DIAGNOSIS OF HUMAN UTERUS MYOMENIC
AU2002365941A8 (en) Methods of diagnosis, monitoring and treatment of fertility
AU2001289930A1 (en) Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
GB0120009D0 (en) Cause and effect diagnosis
GB0106316D0 (en) Apparatus for use in the treatment of hair
DE29717031U1 (de) Vorrichtung zur Pflege des menschlichen Körpers
EP1482960A4 (en) PROCESSES AND PRODUCTS FOR THE MOUTH CARE
DE29819571U1 (de) Vorrichtung zur Pflege des menschlichen Körpers
AU2001291256A1 (en) Methods and compositions for the identification, assessment and therapy of human cancers
GB0130769D0 (en) Aqueous effervescing hair treatment